Tag Archives: vaccines

Where's the Vaccine for Meningitis B?

The bacterial meningitis outbreak at Princeton University in recent weeks has raised questions about why there is no vaccine in US to prevent this deadly disease, when such a therapy is approved in Europe and Australia. The current Princeton health danger prompted the Centers for Disease Control and Prevention (CDC) to request emergency import of […]
Posted in Europe, FDA, Global, Market Access, R&D, Safety, Strategy | Also tagged , , , , , | Leave a comment

PhRMA Research and Hope Awards Gives Industry a Shot in the Arm

Vaccines–once the neglected also ran in big Pharma’s armamentarium of innovations–received top billing at PhRMA’s annual Research and Hope awards held at the Washington Newseum on September 11.  More than 200 industry executives, politicians and scientists recognized the accomplishments of three separate teams in developing and building access to  preventive vaccines.
Posted in Events, healthcare, R&D | Also tagged , , , , , , , , , , , | Leave a comment

UN Pact Scuttles Anti-Vaccine Provision

A new international agreement to reduce mercury contamination of air and water was recently adopted by 140 countries, without a proposal that threatened to limit access to vaccines in much of the world. The credit goes to public health authorities and medical experts who challenged a provision blocking production of vaccines with the preservative thimerosal, […]
Posted in Emerging Markets, FDA, Global, healthcare, Legal, Market Access, Patient Communication, Safety | Also tagged , , , , , | 2 Comments

Can Sanofi's Expanding Predictive Modeling Technology Enhance the Productivity of R&D?

As the hurdles to successful commercialization of new medicines continue to mount, the ability to find and exploit cost efficiencies in the development process has become a critical source of competitive advantage.  This is true not only for biologic drugs but also increasingly for vaccines, now a high growth segment of the medicines business, with […]
Posted in Biotech | Also tagged , , | Leave a comment

GSK to Cut 1,800 Sales Positions (Updated)

GlaxoSmithKline, today, announced that it is restructuring its US pharmaceutical sales organization. The plan will include elimination of 1,800 sales rep positions by year end. The cuts will affect approximately 1,000 employees and an undetermined number of support staff. A spokesperson told Pharm Exec that some reps will be moved to the company’s expanding vaccine […]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta